Key Market Indicator:
In this news category you will find information from and about companies, organizations, institutions, products of all kinds and in a broad spectrum. To get a quick overview of current trends and developments, it's worth visiting daily.
CH0461929603
Thu, 15.09.2022
Xlife Sciences AG
Xlife Sciences AG
/ Key word(s): Miscellaneous
Baader Bank initiates research coverage on Xlife Sciences
15.09.2022 / 07:00 CET/CEST
Baader Bank, one of the leading European partners for investment and banking services, has initiated its research coverage on Xlife Sciences (SIX: XLS). The initial analyst report published today st [ … ]
Thu, 15.09.2022
Xlife Sciences AG
Xlife Sciences AG
/ Key word(s): Miscellaneous
Baader Bank initiates research coverage on Xlife Sciences
15.09.2022 / 07:00 CET/CEST
Baader Bank, one of the leading European partners for investment and banking services, has initiated its research coverage on Xlife Sciences (SIX: XLS). The initial analyst report published today st [ … ]
Mon, 22.08.2022
Xlife Sciences AG
Xlife Sciences AG
/ Key word(s): Miscellaneous
Intron Health initiates research coverage of Xlife Sciences
22.08.2022 / 07:00 CET/CEST
Intron Health today published its first independent research report on Xlife Sciences (SIX: XLS). The coverage starts with a «Buy» rating and a target price of CHF 47. Intron Health has evaluated [ … ]
Mon, 22.08.2022
Xlife Sciences AG
Xlife Sciences AG
/ Key word(s): Miscellaneous
Intron Health initiates research coverage of Xlife Sciences
22.08.2022 / 07:00 CET/CEST
Intron Health today published its first independent research report on Xlife Sciences (SIX: XLS). The coverage starts with a «Buy» rating and a target price of CHF 47. Intron Health has evaluated [ … ]
Mon, 04.07.2022
Xlife Sciences AG
Xlife Sciences AG
/ Key word(s): Miscellaneous
FUSE-AI supports German pharmacies in digitization
04.07.2022 / 07:01
Xlife Sciences’ (SIX: XLS) project company FUSE-AI has been appointed as strategic partner in the field of digitization by the pharmacy associations and federations of all 16 German federal states. FUSE-AI and the [ … ]
Mon, 04.07.2022
Xlife Sciences AG
Xlife Sciences AG
/ Key word(s): Miscellaneous
FUSE-AI supports German pharmacies in digitization
04.07.2022 / 07:01
Xlife Sciences’ (SIX: XLS) project company FUSE-AI has been appointed as strategic partner in the field of digitization by the pharmacy associations and federations of all 16 German federal states. FUSE-AI and the [ … ]
Mon, 16.05.2022
Xlife Sciences AG
Xlife Sciences AG
/ Key word(s): Miscellaneous
Project company Xsight Optics successfully participates in start-up competition – prize money finances relevant R&D project
16.05.2022 / 07:05
Xsight Optics, based in Jena (Germany), a project company of Xlife Sciences AG (SIX: XLS), has successfully participated in this year's [ … ]
Wed, 01.12.2021
Xlife Sciences AG
DGAP-Media / 01.12.2021 / 08:00
DGAP Press release
December 1, 2021 08.00 am CET
Media release
Xlife Sciences appoints new Chief Financial Officer
Xlife Sciences (XLS DE) announced that Carl von Halem has been appointed as the Company's new Chief Financial Officer, effective as of today, 1 December 2021. Beat Kläui, who has been interim [ … ]
Thu, 07.10.2021
Xlife Sciences AG
DGAP-Media / 07.10.2021 / 09:05
MEDIA INFORMATION
Xlife Sciences AG (XLS DE): Successful license deal with Vitese Trading GmbHInflamed pharma GmbH signs license agreement with Vitesse Trading GmbH
The Xlife-project company inflamed pharma GmbH has concluded an exclusive license agreement with the Austrian Vitesse Trading GmbH for the sale [ … ]
Tue, 22.06.2021
Xlife Sciences AG
DGAP-Media / 22.06.2021 / 06:50
PRESS RELEASE
Zurich,Xlife Sciences AG (XLS DE): Collaboration with the University of Marburg
Inventum Genetics GmbH and Universität Marburg agree on a collaborationThe project company of Xlife Sciences AG Inventum Genetics GmbH has signed a collaboration agreement with the Philipps-University of Marburg. In [ … ]